These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1397036)

  • 1. Quinacainol, a new antiarrhythmic with class I antiarrhythmic actions in the rat.
    Howard PG; MacLeod BA; Walker MJ
    Eur J Pharmacol; 1992 Aug; 219(1):1-8. PubMed ID: 1397036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrical stimulation studies with quinacainol, a putative 1C agent, in the anaesthetised rat.
    Howard PG; Walker MJ
    Proc West Pharmacol Soc; 1990; 33():123-7. PubMed ID: 2274522
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
    Beatch GN; Abraham S; MacLeod BA; Yoshida NR; Walker MJ
    Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
    Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289.
    Pugsley MK; Saint DA; Penz MP; Walker MJ
    Br J Pharmacol; 1993 Dec; 110(4):1579-85. PubMed ID: 8306104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Block of NA+ and K+ currents in rat ventricular myocytes by quinacainol and quinidine.
    Pugsley MK; Walker MJ; Saint DA
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):60-5. PubMed ID: 15730436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic properties of tetrodotoxin against occlusion-induced arrhythmias in the rat: a novel approach to the study of the antiarrhythmic effects of ventricular sodium channel blockade.
    Abraham S; Beatch GN; MacLeod BA; Walker MJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1166-73. PubMed ID: 2557414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new ECG measure (RSh) for detecting possible sodium channel blockade in vivo in rats.
    Penz W; Pugsley M; Hsieh MZ; Walker MJ
    J Pharmacol Toxicol Methods; 1992 Mar; 27(1):51-8. PubMed ID: 1316193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular arrhythmia incidence in the rat is reduced by naloxone.
    Pugsley MK; Hayes ES; Wang WQ; Walker MJ
    Pharmacol Res; 2015 Jul; 97():64-9. PubMed ID: 25920674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic effects of U-50,488H in rats subject to coronary artery occlusion.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Eur J Pharmacol; 1992 Feb; 212(1):15-9. PubMed ID: 1555635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiarrhythmic efficacy of intravenous anipamil against occlusion and reperfusion arrhythmias.
    MacLeod BA; Moult M; Saint KM; Walker MJ
    Br J Pharmacol; 1989 Dec; 98(4):1165-72. PubMed ID: 2611487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiarrhythmic actions of bisaramil and penticainide result from mixed cardiac ion channel blockade.
    Pugsley MK; Hayes ES; Saint DA; Walker MJA
    Biomed Pharmacother; 2019 Mar; 111():427-435. PubMed ID: 30594781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia.
    Fagbemi O; Kane KA; Leprán I; Parratt JR; Szekeres L
    Br J Pharmacol; 1983 Mar; 78(3):455-60. PubMed ID: 6301599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying the antiarrhythmic properties of beta-adrenoceptor blockade against ischaemia-induced arrhythmias in acutely prepared rats.
    Paletta MJ; Abraham S; Beatch GN; Walker MJ
    Br J Pharmacol; 1989 Sep; 98(1):87-94. PubMed ID: 2572292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat.
    Curtis MJ; MacLeod BA; Walker MJ
    Br J Pharmacol; 1984 Oct; 83(2):373-85. PubMed ID: 6487902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KC8851, a tedisamil analogue with mixed channel blockade, exhibits antiarrhythmic properties against ischemia- and electrically-induced arrhythmias.
    Xu R; Abraham S; McLarnon JG; Walker MJ
    Life Sci; 1997; 61(3):237-48. PubMed ID: 9217283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the electrophysiologic, antiarrhythmic and haemodynamic profile of a new isoquinolinedione derivative.
    Gülker H; Spyra W; Thale J; Krimphove F; Hübner A; Bender F
    Arzneimittelforschung; 1987 Aug; 37(8):917-9. PubMed ID: 3675686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class III antiarrhythmic action linked with positive inotropy: antiarrhythmic, electrophysiological, and hemodynamic effects of the sea-anemone polypeptide ATX II in the dog heart in situ.
    Platou ES; Refsum H; Hotvedt R
    J Cardiovasc Pharmacol; 1986; 8(3):459-65. PubMed ID: 2425158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents.
    Allan G; Donoghue S; Follenfant MJ; Sawyer DA
    Br J Pharmacol; 1986 Jun; 88(2):333-43. PubMed ID: 3730698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.